Transurethral resection of the prostate: one-year experience in a single centre
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242202Keywords:
Benign prostatic hyperplasia, Prostate, TURPAbstract
Background: Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms among older males. Transurethral resection of the prostate (TURP) still remains the gold standard in the treatment of benign prostatic hyperplasia. However, its availability is not widespread in most public healthcare facilities across sub-Saharan Africa. This study was designed to describe and share our experience of TURP in a single centre.
Methods: This is a retrospective evaluation of 64 patients who had TURP for bladder outlet obstruction secondary to enlarged prostate. The records of men who had TURP over a period of one year (January 2022-December 2022) were retrieved and reviewed. The pre-operative prostate specific antigen (PSA), pre-operative ultrasound measured size of prostate, resected weight of prostate, duration of surgery, duration of hospital stay, indication for TURP and complications were analysed.
Results: Sixty-four patients had TURP done during the period under review. The age range was 50-90 years (mean 68.33), the pre-operative prostate gland weight was 76.78gm. The mean resected weight was 53.9gm. The pre-operative serum prostate specific antigen PSA had a minimum value of 1.5ng/ml and the maximum was 50.8ng/ml with mean value of 13.8ng/ml. The mean duration of surgery was 55.73 minutes and the mean duration of hospital stay was 3 days. The most common indication for TURP was lower urinary tract symptoms. We recorded four complications; capsule perforation, clot retention, hypotension and stress incontinence, 60 patients had no complications.
Conclusions: Transurethral resection of the prostate is an effective surgical treatment for benign prostatic hyperplasia, it is associated notable improvement in the patient’s quality of life and minimal complications.
Metrics
References
Nwafor CC, Keshinro OS, Abdu EK. A histopathological study of prostate lesions in Lagos, Nigeria: A private practice experience. Niger Med J. 2015;56(5):338-43.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.
Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asia J Urol. 2017;4(3):148-51.
Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol. 2006;46(6):970-8.
Shvero A, Calio B, Humphreys MR, Das AK. HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia. Can J Urol. 2021;28(S2):6-10.
Tuhkanen K, Heino A, Aaltomaa S, Ala-Opas M. long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostate hyperplasia with small or moderately enlarged prostates. Scand J Urol Nephrol. 2003;37(6):487-93.
Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M. Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data. Miner Urol Nefrol. 2009;61(3):309-24.
Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochr Datab Syst Rev. 2012;12(9):CD004135.
Mbaeri TU, Abiahu JA, Obiesie EA, Odo C, Oranusi KC, Nwafor AME, et al. Assessment of complications of transurethral resection of the prostate using Clavien-Dindo classification in South Eastern Nigeria. Niger J Surg. 2020;26:142-6.
Nnabugwu II. Ugwumba FO, Udeh EI, Ozoemena OF. Learning transurethral resection of the prostate: A comparison of the weight of resected specimen to the weight of enucleated specimen in open prostatectomy. Niger J Clin Pract. 2017;20(12):1590-5.
Harraz AM, El-Assmy A, Thartwat M, Elshal AM, El-Nahas AR, Barakat TS, et al. Predicting the resected tissue weight from a digital rectal examination and total prostate specific antigen level before resection of the prostate. Arab J Urol 2014;12(4):256-61.
Alhasan S, Aji S, Mohamed AZ, Malami S. Transurethral resection of the prostate in Nigeria, problems and prospects. BMC Urol. 2008;8:18.
Young MJ, Elmussareh M, Morrison T, Wilson JR. The changing practice of transurethral resection of the practice. Ann R Coll Surg Engl. 2018;100(4):326-9.
Tela UM, Lawan AM, Olajide BD. Monopolar transurethral resection of prostate: our initial experience in a new African hospital with few resources. Int Surg J. 2020;7(11):3546-9.
Vaz AS, Ribeiro S, Lopes JD, Figueiredo E. Transurethral resection of the prostate-like syndrome after double-j replacement in a patient with chronic spinal cord Injury: Case Report. J Endourol Case Rep. 2020;6(4):336-8.
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complication. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989;141(2):243-7.
Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 1999;53(1):98-105.
Chukwujama, Oguike T, Azike J. Transurethral resection of the prostate a 3-year experience. Niger J Surg. 2011;17(1):15-8.
Rahman MM, Gupta SD, Mridha NI, Wahid M, Begum F. Comparative study between outcome of early and conventional catheter removal after transurethral resection of prostate. Bangladesh J Urol. 2017;20(2):82-86.
Khan A. Day care monopolar transurethral resection of prostate: Is it feasible? Urol Ann. 2014;6(4):334-9.
Akpayak I, Shuaibu S, Onowa V, Nabasu L, Galam Z. Monopolar transurethral resection of the prostate for benign prostatic hyperplasia: What are the outcomes and complications in our patients? Niger J Med. 2017;26(2):173-7.
Chimaobi GO, John ER, Nuhu KD, Samaila IS, Julius A, Isaac MY. Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate. Pan Afri Med J. 2021;39(165).